Lactobacillus side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Lactobacillus (lactobacillus). Common side effects include coma among females and death among males.
The phase IV clinical study is created by eHealthMe based on 5,768 reports from the FDA, and is updated regularly.
What is Lactobacillus?
Lactobacillus has active ingredients of lactobacillus. It is often used in stomach discomfort. eHealthMe is studying from 5,854 Lactobacillus users. Check the latest studies of Lactobacillus.
5,768 people who take Lactobacillus and have side effects are studied.
What are the common side effects of Lactobacillus, by gender? *
What are the common side effects of Lactobacillus, by age (0-1 to 60+)? *
What are the common side effects of Lactobacillus, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Lactobacillus?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on lactobacillus (the active ingredients of Lactobacillus) and Lactobacillus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Lactobacillus:
- Lactobacillus (5,854 reports)
All Lactobacillus side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- High Blood Pressure in Leflunomide, how severe and when it was recovered? - now
- Metformin and Left Ventricular Hypertrophy for Men aged 60+ - 4 seconds ago
- Drug interactions of Celexa and Milk Thistle - 10 seconds ago
- Cholestyramine and Stress And Anxiety for Women aged 60+ - 11 seconds ago
- Cholestyramine and Anxiolytic Therapy for Women aged 60+ - 12 seconds ago
- Cholestyramine and Anxiety And Stress for Women aged 60+ - 12 seconds ago
- Cholestyramine and Stress for Women aged 60+ - 12 seconds ago
- Cholestyramine and Anxiety, Apprehension, Feeling Uptight, Jitters, Stress, Stress And Anxiety, Tension for Women aged 60+ - 12 seconds ago
- Cholestyramine and Jitters for Women aged 60+ - 13 seconds ago
- Cholestyramine and Feeling Uptight for Women aged 60+ - 13 seconds ago